Stress-Induced Hyperglycemia Predicts Poor Outcomes in Primary Intracerebral Hemorrhage Patients

Kevin Gilotra1, Jade Basem1, Melissa Janssen2

  • 1Renaissance School of Medicine at Stony Brook University, Stony Brook, NY 11794, USA.

Neurosci
|February 21, 2025
PubMed

Insights

Stress-induced hyperglycemia (SIH) in non-diabetic patients with intracerebral hemorrhage (ICH) predicts worse outcomes than diabetes-related hyperglycemia. SIH is a stronger predictor of poor outcomes in ICH patients.

Area of Science:

  • Neurology
  • Endocrinology
  • Critical Care Medicine

Background:

  • Hyperglycemia is linked to poor outcomes in intracerebral hemorrhage (ICH).
  • Stress-induced hyperglycemia (SIH) occurs in non-diabetic patients, distinct from chronic hyperglycemia in diabetes mellitus (DM).
  • The differential impact of SIH versus DM-related hyperglycemia on ICH outcomes requires investigation.

Purpose of the Study:

  • To investigate the influence of hyperglycemia on primary ICH patient outcomes.
  • To compare outcomes between patients with SIH and those with DM-related hyperglycemia.
  • To identify hyperglycemia as a predictor of outcomes in ICH.

Main Methods:

  • Retrospective analysis of 636 primary ICH patients (January 2011-December 2022).
  • Data collected: admission glucose, pre-existing DM, inpatient mortality, modified Rankin Scale (mRS) scores.
  • Regression models compared outcomes between hyperglycemic/diabetic patients and normoglycemic/non-diabetic controls.

Main Results:

  • SIH patients exhibited significantly higher inpatient mortality and worse mRS scores (p < 0.001).
  • Hyperglycemia secondary to DM was also associated with higher mortality and worse mRS scores.
  • The association between SIH and poor outcomes was stronger than that for DM-related hyperglycemia.

Conclusions:

  • SIH appears to be a more significant predictor of poor outcomes in ICH patients than chronic hyperglycemia from DM.
  • Further prospective studies are needed to understand the impact of dynamic glucose changes on ICH outcomes.
  • This research highlights the importance of managing acute hyperglycemia in ICH.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
149
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
497
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
676
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
843
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K